Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti Moscow Region reported for 3 months of 2024 by RAS

4/27/24 MSRS

Rosinter reported for 2023 by IFRS

4/27/24 ROST

Kaluga Sales Company reported for 3 months of 2024 by RAS

4/27/24 KLSB

Unipro reported for 3 months of 2024 by RAS

4/27/24 UPRO

EuroTrans reports for 2023 by IFRS

4/27/24 EUTR

Aeroflot reported for 3 months of 2024 by RAS

4/27/24 AFLT

Board of Directors of Magnitogorsk Iron and Steel Works recommended that dividends be paid for 2023

4/27/24 MAGN

Volgogradenergosbyt reported for 3 months of 2024 by RAS

4/27/24 VGSB

Board of Directors of Europlan recommended that dividends be paid for 2023

4/27/24 LEAS

Board of Directors of UK Arsagera recommended that dividends be paid for 2023

4/27/24 ARSA